To investigate whether FGF8-dependent survival signaling is involved in nRCT resistance in rectal cancer, expression levels of FGF8 and the anti-apoptotic protein Survivin were analyzed using immunohistochemistry (IHC) in human rectal cancer tissue obtained from pre-nRCT biopsies and surgical specimens. This evidence concerns the gene FGF8 and rectal cancer.